Evidence map›Paper›PMID 42609297›Full record

ArticleCureus2026

Fatal Outcome of Widespread Cranial Basal Cell Carcinoma Due to Intraparenchymal Brain Extension in a Setting of Local Recurrences.

Tayler Gant, Serguei Bannykh, David Frishberg

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tayler GantDepartment of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
Serguei BannykhDepartment of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
David FrishbergDepartment of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Basal cell carcinoma (BCC) is one of the most commonly encountered carcinomas; however, progression to invasive or locally advanced disease is extremely rare. The clinical course of locally advanced BCC is typically aggressive and has a poorer prognosis with variable survival. We present the case of a 58-year-old unhoused female with recurrent BCC of the left cranial vertex who underwent excision at an outside hospital. Intraoperative frozen section margins were negative for BCC; however, permanent sections demonstrated widespread residual tumor with morpheaform histology involving the parietal bone and aponeurosis at the deep margins. She subsequently underwent re-excision, multiple reconstructive procedures with grafts from the bilateral thighs, left forearm, and back, and immunotherapy with vismodegib. In September 2025, she presented with right upper extremity weakness and headache. Magnetic resonance imaging (MRI) revealed osteomyelitis and a left intra- and periventricular parietal fluid collection consistent with an abscess. She underwent left hemicraniectomy with wound debridement and full-thickness skin grafting. Histology demonstrated infiltrative nests and irregular strands of basaloid cells with peripheral palisading invading the skin, parietal bone, and brain parenchyma. Management included repeated wound debridement, full-thickness skin grafting, and consideration of adjuvant radiation to reduce recurrence after grafting. Three free-flap reconstructions with revisions were required because of infection, wound progression, and dehiscence. Persistent infection and a nonhealing wound ultimately precluded further surgical intervention. She was transitioned to comfort care and died in October 2025. This is a unique case of recurrent invasive and locally advanced BCC that supports the notion that this is an aggressive form of the more common indolent cancer seen in daily practice. Emphasis on early detection and intervention is vital in these particularly aggressive cases.

Indexed as

basal cell carcinoma diagnosisbasal cell carcinoma of scalpinvasive basal cell carcinomamorphea basal cell carcinomasurgical excision of basal cell carcinoma

Identifiers

PMID42609297
PMCPMC13477868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.